These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4452587)

  • 21. Hepatitis B infection in Yemenis in Sana'a: pattern and risk factors.
    Al-Nassiri KA; Raja'a YA
    East Mediterr Health J; 2001; 7(1-2):147-52. PubMed ID: 12596964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B surface antigen in Kashmiri blood donors.
    Makroo RN; Hassain G; Koul A; Shah GN
    Indian J Med Res; 1989 Sep; 89():310-3. PubMed ID: 2628293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B antigen - post transfusion studies in Papua New Guinea.
    Woodfield DG
    Trop Geogr Med; 1977 Sep; 29(3):257-65. PubMed ID: 595131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfusion-hepatitis, the problem in the field of blood transfusion].
    Krebs HJ
    Schweiz Rundsch Med Prax; 1973 Sep; 62(36):1099-104. PubMed ID: 4728429
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of the frequency of carrier state of hepatitis associated antigen (HAA) in donors (according to data of the Zaporozhye district blood transfusion center)].
    Rakitianskaia VN; Skorobogataia EM
    Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):48-9. PubMed ID: 4832849
    [No Abstract]   [Full Text] [Related]  

  • 26. Australia antigen and post-transfusion hepatitis.
    Taylor DG
    J Tenn Med Assoc; 1973 Apr; 66(4):351-2. PubMed ID: 4696863
    [No Abstract]   [Full Text] [Related]  

  • 27. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 28. [Remarks on the problem of Australia antigen as an etiologic factor in the outbreak of viral hepatitis].
    Drews J; Sachs V; Waldvogel B
    Dtsch Med Wochenschr; 1971 Nov; 96(48):1893-4. PubMed ID: 5119935
    [No Abstract]   [Full Text] [Related]  

  • 29. A prospective study of posttransfusion hepatitis. The role of Australia Antigen.
    Gocke DJ
    JAMA; 1972 Feb; 219(9):1165-70. PubMed ID: 5066869
    [No Abstract]   [Full Text] [Related]  

  • 30. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 31. [Does a "hepatitis C" besides hepatitis B play an important part in blood transfusion disorders?].
    Frösner G
    Internist (Berl); 1976 May; 17(5):256-7. PubMed ID: 58848
    [No Abstract]   [Full Text] [Related]  

  • 32. [Viral hepatitis morbidity in blood recipients].
    Grinshteĭn EA; Aleĭnik MD; Klimova NIa; Makarevich IK; Karavashkina EV
    Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):16-9. PubMed ID: 7279883
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence of hepatitis B surface antigen (HBsAg) in and around Delhi.
    Sebastian M; Sarin SK; Salhan RN; Verma MC; Passey MN; Anand BR
    J Commun Dis; 1986 Mar; 18(1):22-7. PubMed ID: 3745861
    [No Abstract]   [Full Text] [Related]  

  • 34. [Asymptomatic carriers of hepatitis B associated antigen (HBsAg) in blood donors in Quebec].
    Valet JP; Rousseau C; Ackermann HW
    Union Med Can; 1977 Jul; 106(7):966-9. PubMed ID: 898408
    [No Abstract]   [Full Text] [Related]  

  • 35. The frequency of the Australia antigen in 1845 blood donors from Budapest.
    Joó-Szabados T; Filonenko A; Seres-Tóth E; Gulyás V
    Ann Immunol Hung; 1973; 17():149-52. PubMed ID: 4805804
    [No Abstract]   [Full Text] [Related]  

  • 36. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis.
    Hollinger FB; Aach RD; Gitnick GL; Roche JK; Melnick JL
    N Engl J Med; 1973 Aug; 289(8):385-91. PubMed ID: 4719826
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution of viral hepatitis associated antigens and antibodies in the normal population].
    Costantino D; Del Prete S; Doglia M; Fabiani MP; Iacini A; Peraldo A; Campanella F
    Boll Ist Sieroter Milan; 1972; 51(3):211-6. PubMed ID: 4120021
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis associated antigen carriers among blood donors in Greece.
    Hadziyannis S; Merikas G; Panetsos S; Kourepi M
    Am J Dis Child; 1972 Apr; 123(4):381-3. PubMed ID: 4623823
    [No Abstract]   [Full Text] [Related]  

  • 39. Australia antigen in blood donors in Vellore.
    Hill PG; John TJ; Shanmugham RV; Carman RH
    Indian J Med Res; 1973 Mar; 61(3):378-82. PubMed ID: 4756211
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serum hepatitis in donors and recipients].
    Khazanov AI; Stulov AP; Korolev SS; Ivlev AS; Verteletskiĭ VV
    Voen Med Zh; 1978 Dec; (12):41-3. PubMed ID: 734959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.